N-LIfT shows potent cancer killing across multiple solid tumour types
LIfT BioSciences announces its N-LIfT cell therapy shows tumour destruction across five different solid tumour types in PDX tumouroid...
Sep 13, 2022
N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid
London, 6th March 2022 – LIfT BioSciences,a biotech bringing to market a first-in-class allogeneic innate cell therapy, today announces...
Mar 6, 2022
LIfT BioSciences secures its largest financing to date with a further £5m
London, 21st January 2022 – Biotech LIfT BioSciences today announced its largest financing round to date with a further £5m investment...
Jan 21, 2022
LIfT BioSciences & King’s College London embark on an exciting new collaboration
London, 26 March – LIfT BioSciences announced today that they have embarked on a collaboration with King’s College London, under the...
Mar 26, 2021
LIfT BioSciences N-LIfT Cell Therapy Successfully Infiltrates Pancreatic Tumours In-vivo
London, 9 November 2020 – LIfT BioSciences, a biotech company developing a first in class innate cell therapy with the potential to...
Nov 9, 2020
